FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation (HCT) is associated with high mortality. Purpose: We hypothesized that FAM (inhaled Fluticasone, Azithromycin, and Montelukast) with a brief steroid pulse could avert progression of new-onset BOS. Experimenta...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Williams, Kirsten M., Cheng, Guang-Shing, Pusic, Iskra, Jagasia, Madan, Burns, Linda, Ho, Vincent T., Pidala, Joseph, Palmer, Jeanne, Johnston, Laura, Mayer, Sebastian, Chien, Jason W., Jacobsohn, David A., Pavletic, Steven Z., Martin, Paul J., Storer, Barry E., Inamoto, Yoshihiro, Chai, Xiaoyu, Flowers, Mary E.D., Lee, Stephanie J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801753/
https://ncbi.nlm.nih.gov/pubmed/26475726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi